EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Targeted and Controlled Drug Delivery Strategies for Overcoming Limitations of Conventional Tuberculosis Treatment: A Comprehensive Review

Raj Kumar Mandal

International Journal of Sciences and Innovation Engineering · 2025

DOI: 10.70849/ijsci02092025038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Sciences and Innovation Engineering, 2025. Verfasst von Raj Kumar Mandal. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB) remains one of the leading infectious diseases worldwide and has been further complicated by multidrug resistance, poor patient compliance and toxicities related to drug regimens. Conventional therapy is based on long-term multi-drug regimens with poor tissue penetration of the granulomatous lesions and often in association with resistance. Various types of carriers such as nanoparticles, liposomes, microspheres, inhaled based carriers are being explored as controlled and targeted drug delivery systems potentially able to circumvent many of these shortcomings by maintaining therapeutic levels while improving site-specific drug activity.

Objective

This review provides a general discussion of the development of new targeted and controlled delivery systems for treatment of TB with special emphasis on their significance for overcoming the limitations of conventional therapy. Methodology: A systematic review of the literature was conducted for the time period 2010 to 2025 using PubMed, Scopus and Science Direct. Tropical studies on controlled release formulations, pulmonary carriers, macrophage targeted systems and new nanocarriers were reviewed.

Results

Controlled Release platforms increase duration of action, reduce dosing frequency and improve compliance. Targeted delivery reduces systemic toxicity increases alveolar macrophages and granulomatous uptake and increases cure rates. Local bioavailability of pulmonary formulation is better than that of oral forms.

Conclusion

Targeted and controlled delivery is a new paradigm for therapy in TB. If they can be successfully translated into clinical practice, they could shorten the duration of therapy, limit the development of drug resistance and maximise benefit from therapy at the global level.

Zitieren

APA

Mandal, R. K. (2025). Targeted and Controlled Drug Delivery Strategies for Overcoming Limitations of Conventional Tuberculosis Treatment: A Comprehensive Review. International Journal of Sciences and Innovation Engineering. https://doi.org/10.70849/ijsci02092025038

Vancouver

Mandal RK. Targeted and Controlled Drug Delivery Strategies for Overcoming Limitations of Conventional Tuberculosis Treatment: A Comprehensive Review. International Journal of Sciences and Innovation Engineering. 2025. doi:10.70849/ijsci02092025038

BibTeX
@article{Mandal2025,
  author = {Mandal, Raj Kumar},
  title = {Targeted and Controlled Drug Delivery Strategies for Overcoming Limitations of Conventional Tuberculosis Treatment: A Comprehensive Review},
  journal = {International Journal of Sciences and Innovation Engineering},
  year = {2025},
  doi = {10.70849/ijsci02092025038}
}
Kostenlos starten →